Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel and bryostatin-1 in advanced pancreatic cancer completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) [Phase 2]
A Phase 2 trial (PESUP) evaluating pancreatic enzyme supplementation in unresectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer [Phase 2]
Phase 2 trial evaluating GI-4000 in combination with gemcitabine versus placebo for non-metastatic, post-resection pancreatic cancer has com…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma [Phase 1, Phase 2]
Phase I/II open-label dose-escalation study of PHY906 plus capecitabine in advanced pancreatic cancer evaluated safety and preliminary effic…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer [Phase 3]
A Phase 3 trial of neoadjuvant gemcitabine/oxaliplatin followed by adjuvant gemcitabine in resectable pancreatic cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle [NA]
Clinical trial comparing EUS-FNA to EUS-FNB with a novel core biopsy needle in pancreatic cancer and related conditions; completed with resu…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating dasatinib in combination with gemcitabine for locally advanced pancreatic cancer has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluated simtuzumab in combination with gemcitabine for metastatic pancreatic cancer, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy [Phase 3]
Phase 3 trial comparing acute normovolemic hemodilution versus standard intraoperative management in patients undergoing hepatic resection a…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
Clinical trial update for INST 0603C in unresectable/metastatic pancreatic cancer; study terminated with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride with or without vismodegib in patients with recurrent or metastatic pancreatic cancer; re…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer [Phase 2]
This is a Phase 2 dose-escalation study of Erlotinib (Tarceva) in combination with Gemcitabine for metastatic pancreatic cancer. The trial c…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine with Abraxane and other investigational therapies as neoadjuvant treatment for pancreatic adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
This is an update on a Phase 2 clinical trial evaluating cone-beam CT guided stereotactic radiation therapy for locally advanced pancreatic …
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 safety study evaluating radiofrequency ablation for locally advanced pancreatic cancer has completed and reported safety findings.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating FOLFOXIRI as primary treatment for locally advanced pancreatic cancer (Stage III) has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without gemcitabine in metastatic pancreatic cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study [NA]
The document reports a completed study using 18F-HX4 PET imaging to assess tumor hypoxia in gastrointestinal cancers, focusing on optimizati…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Chemotherapy With or Without Enoxaparin in Pancreatic Cancer [Phase 2, Phase 3]
A Phase 2/3 trial evaluating chemotherapy with versus without enoxaparin in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating the combination of lapatinib ditosylate and capecitabine in patients with metastatic pancreatic cancer; the study…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib for stage III or stage IV pancreatic cancer was terminated; results were posted on 2014-12-10.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 study evaluating gemcitabine with fish oil in advanced pancreatic cancer has completed; no results are provided in the excerpt.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy [Phase 3]
A Phase 3 trial comparing nonstented stump-closed pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduode…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC) [Phase 1]
This Phase 1 trial evaluated gemcitabine with high-dose intravenous vitamin C in metastatic pancreatic cancer. The study was terminated, and…
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer [Phase 2]
Phase 2 clinical trial update for RO4929097, a gamma secretase inhibitor, in patients with previously treated metastatic pancreatic cancer. …